» Articles » PMID: 29705704

FOXM1 Promotes Proliferation in Human Hepatocellular Carcinoma Cells by Transcriptional Activation of CCNB1

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2018 Apr 30
PMID 29705704
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor Forkhead box protein M1 (FOXM1) plays critical roles in cancer development and progression, including human hepatocellular carcinoma (HCC). However, the regulatory role and underlying mechanisms of FOXM1 is still limited. Here, we found that the high level expression of FOXM1 and CCNB1 is closely associated with poor prognosis in HCC patients. And FOXM1 and CCNB1 were overexpressed concomitantly in liver tumor tissues. Knockdown of FOXM1 significantly inhibited the expression levels of CCNB1 in HCC cell lines at both the mRNA and protein levels. Mechanistic studies revealed that FOXM1 binds directly to the promoter region of CCNB1 and regulates the expression levels of the CCNB1 gene in the transcriptional level. Furthermore, the loss of functional and rescue experiments showed that CCNB1 is essential for FOXM1-driven proliferation in HCC cells. In the present study, our results partially explained the dysregulated expression of FOXM1 play an important role in proliferation of human hepatocellular carcinoma cells via transcriptional activation of CCNB1 expression. And it also highlights a FOXM1/CCNB1 axis could be a potential target for the treatment of HCCs.

Citing Articles

Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma.

Huang L, Wu S, Liu Y, Liu H, Chien P, Lin H Int J Mol Sci. 2024; 25(22).

PMID: 39596041 PMC: 11593742. DOI: 10.3390/ijms252211969.


A Bioinformatics-Based Approach to Discover Novel Biomarkers in Hepatocellular Carcinoma.

Shourideh A, Maddah R, Amiri B, Basharat Z, Shadpirouz M Iran J Public Health. 2024; 53(6):1332-1342.

PMID: 39430152 PMC: 11488550.


A Gluconeogenesis-Related Genes Model for Predicting Prognosis, Tumor Microenvironment Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.

Tang X, Xue J, Zhang J, Zhou J J Hepatocell Carcinoma. 2024; 11:1907-1926.

PMID: 39386981 PMC: 11463187. DOI: 10.2147/JHC.S483664.


Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis.

Moghimi A, Bani Hosseinian N, Mahdipour M, Ahmadpour E, Miranda-Bedate A, Ghorbian S Cancer Rep (Hoboken). 2024; 7(8):e2152.

PMID: 39118438 PMC: 11310554. DOI: 10.1002/cnr2.2152.


Antiproliferative Activity of -Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition.

Andrade A, Pauli F, Pressete C, Zavan B, Hanemann J, Miyazawa M Biomedicines. 2024; 12(4).

PMID: 38672246 PMC: 11048582. DOI: 10.3390/biomedicines12040892.